Follow The Filings

MRVI position history

The shares of Maravai Lifesciences (MRVI) that First Pacific Advisors, LP reported in each quarter’s 13F.

Equity, COM CL A

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q2: 741,332 shares, $1.8M, 0.03% of portfolio, New
  2. 2025 Q3: 884,883 shares, $2.5M, 0.04% of portfolio, Add +19.4%
  3. 2025 Q4: 884,883 shares, $2.9M, 0.04% of portfolio
  4. 2026 Q1: 884,883 shares, $2.5M, 0.04% of portfolio
  5. 2026 Q2: 884,883 shares, $5.5M, 0.07% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders